Back

Heparin and low-molecular-weight heparin switch associated with an increase in bleeding complications in patients on apixaban undergoing catheter ablation: The AMPER ABLATION study

1 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 2 - Drug treatment for atrial fibrillation Rhythm Control, Catheter Ablation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Walid Amara

Centre Hospitalier Intercommunal Le Raincy-Montfermeil, Le Raincy-Montfermeil (France)

9 More presentations in this session

Presentation thumbnail
Doctor G. Montrasio (Aarau, CH)
Abstract Slides
Presentation thumbnail
Doctor M. Mihajlovic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Associate Professor M. Harada (Toyoake, JP)
Abstract
Presentation thumbnail
Doctor O. Hajas (Debrecen, HU)
Abstract Slides
Presentation thumbnail
Professor H. Crijns (Maastricht, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Drug treatment for atrial fibrillation

The Event

Event poster

ESC Congress 2019

1 September 2019 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources